Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

1.

Positioning new treatments in the management of immune thrombocytopenia.

Arnold DM.

Pediatr Blood Cancer. 2013;60 Suppl 1:S19-22. doi: 10.1002/pbc.24341. Epub 2012 Oct 25. Review.

PMID:
23109488
[PubMed - indexed for MEDLINE]
2.

Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.

Gudbrandsdottir S, Frederiksen H, Hasselbalch H.

Platelets. 2012;23(6):423-9. doi: 10.3109/09537104.2011.634931. Epub 2011 Dec 20.

PMID:
22185370
[PubMed - indexed for MEDLINE]
3.

Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.

Makar RS, Zhukov OS, Sahud MA, Kuter DJ.

Am J Hematol. 2013 Dec;88(12):1041-4. doi: 10.1002/ajh.23562. Epub 2013 Sep 12.

PMID:
23913253
[PubMed - indexed for MEDLINE]
4.

Immune thrombocytopenia -- what are the new treatment options?

Hallam S, Provan D, Newland AC.

Expert Opin Biol Ther. 2013 Aug;13(8):1173-85. doi: 10.1517/14712598.2013.801451. Epub 2013 May 17. Review.

PMID:
23682685
[PubMed - indexed for MEDLINE]
5.

TPO receptor agonist for chronic idiopathic thrombocytopenic purpura.

Zeng Y, Duan X, Xu J, Ni X.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008235. doi: 10.1002/14651858.CD008235.pub2. Review.

PMID:
21735426
[PubMed - indexed for MEDLINE]
6.

Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists.

Ghadaki B, Nazi I, Kelton JG, Arnold DM.

Transfusion. 2013 Nov;53(11):2807-12. doi: 10.1111/trf.12139. Epub 2013 Mar 3.

PMID:
23451917
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.

Stasi R, Evangelista ML, Amadori S.

Drugs. 2008;68(7):901-12. Review.

PMID:
18457458
[PubMed - indexed for MEDLINE]
8.

New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.

Kuter DJ.

Eur J Haematol Suppl. 2008 Feb;(69):9-18. doi: 10.1111/j.1600-0609.2007.00999.x. Review.

PMID:
18211568
[PubMed - indexed for MEDLINE]
9.

Thrombopoietin receptor agonists in primary immune thrombocytopenia.

Siegal D, Crowther M, Cuker A.

Semin Hematol. 2013 Jan;50 Suppl 1:S18-21. doi: 10.1053/j.seminhematol.2013.03.005. Review.

PMID:
23664510
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.

Aoki T, Harada Y, Matsubara E, Suzuki T, Oyama T, Kasai M, Uchida T, Ogura M.

J Clin Pharm Ther. 2012 Dec;37(6):729-32. doi: 10.1111/j.1365-2710.2012.01353.x. Epub 2012 May 14.

PMID:
22583038
[PubMed - indexed for MEDLINE]
11.

The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP).

Basciano PA, Bussel J, Hafeez Z, Christos PJ, Giannakakou P.

Br J Haematol. 2013 Jan;160(2):237-43. doi: 10.1111/bjh.12124. Epub 2012 Nov 15.

PMID:
23157319
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.

Chouhan JD, Herrington JD.

Pharmacotherapy. 2010 Jul;30(7):666-83. doi: 10.1592/phco.30.7.666. Review.

PMID:
20575632
[PubMed - indexed for MEDLINE]
13.

Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.

Ghanima W, Lee SY, Barsam S, Miller A, Sandset PM, Bussel JB.

Br J Haematol. 2012 Sep;158(6):811-4. doi: 10.1111/j.1365-2141.2012.09227.x. Epub 2012 Jul 23. No abstract available.

PMID:
22816787
[PubMed - indexed for MEDLINE]
14.

[Trombopag for chronic immune thrombocytopenia in a patient previously treated with romiplostim].

Rodríguez Vargas B, Serna Pérez J, Bermejo Vicedo T.

Farm Hosp. 2013 May-Jun;37(3):265-6. doi: 10.7399/FH.2013.37.3.548. Spanish. No abstract available.

PMID:
23789804
[PubMed - indexed for MEDLINE]
Free Article
15.

The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.

Mahévas M, Fain O, Ebbo M, Roudot-Thoraval F, Limal N, Khellaf M, Schleinitz N, Bierling P, Languille L, Godeau B, Michel M.

Br J Haematol. 2014 Jun;165(6):865-9. doi: 10.1111/bjh.12888. Epub 2014 Apr 12.

PMID:
24725224
[PubMed - indexed for MEDLINE]
16.

[New treatment options for primary immune thrombocytopenia].

Gudbrandsdottir S, Frederiksen H, Birgens HS, Nielsen CH, Nielsen OJ, Stentoft J, Hasselbalch HC.

Ugeskr Laeger. 2011 Jan 24;173(4):271-4. Danish.

PMID:
21262171
[PubMed - indexed for MEDLINE]
17.

New thrombopoietic growth factors.

Kuter DJ.

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S347-56. doi: 10.3816/CLM.2009.s.034. Review.

PMID:
19778863
[PubMed - indexed for MEDLINE]
18.

What is the potential for thrombopoietic agents in acute leukemia?

Kuter DJ.

Best Pract Res Clin Haematol. 2011 Dec;24(4):553-8. doi: 10.1016/j.beha.2011.09.002. Epub 2011 Nov 4. Review.

PMID:
22127320
[PubMed - indexed for MEDLINE]
19.

[Management of refractory ITP with thrombopoietin receptor agonists].

Tomiyama Y.

Rinsho Ketsueki. 2011 Aug;52(8):627-32. Review. Japanese. No abstract available.

PMID:
21897068
[PubMed - indexed for MEDLINE]
20.

Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.

Altomare I, Wasser J, Pullarkat V.

Am J Hematol. 2012 Oct;87(10):984-7. doi: 10.1002/ajh.23275. Epub 2012 Jun 22. Review.

PMID:
22729832
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk